Robert Mentz, MD
Enriched profileAssociate Professor of Medicine (with Tenure), Chief of the Heart Failure Section, Division of Cardiology · Duke University School of Medicine
Robert Mentz is Associate Professor of Medicine (with Tenure), Chief of the Heart Failure Section, Division of Cardiology at Duke University School of Medicine. OpenAlex indexes 986 publications with 31,102 citations (h-index 85); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Robert Mentz, MD, is Associate Professor of Medicine (with Tenure), Chief of the Heart Failure Section, Division of Cardiology at Duke University School of Medicine / Duke University Medical Center, Durham, NC. The public record shows 986 publications with 31,102 citations (h-index 85), centered on Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Diabetes Treatment and Management. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 30 companies, 1 NIH-funded awards (2023–2025).
- Most recent indexed publication: 2026 · Future cardiology
- Top research focus: Heart Failure Treatment and Management
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 30 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 47 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 398.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
Industry payments
Updated 27 Aug 2026
30 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk ASProgram year20256 payments$23,792openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20254 payments$12,600openpaymentsdata.cms.gov ↗
- CVRx, Inc.Program year202522 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.7%Beta blocker17.7%Metoprolol Succinate68%Carvedilol32%Part D≥37 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)15.4%Entresto100%Part D≥30 patientsMetabolism & gastrointestinal
21.6%SGLT2 inhibitor18.2%Jardiance86%Farxiga14%Part D<11 patientsGLP-1 receptor agonist3.4%Ozempic68%Rybelsus32%Part D<11 patientsBlood & clotting
6.7%Factor Xa inhibitor6.7%Eliquis100%Part D≥18 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2023–2025 per NIH RePORTER. The latest:
- Research Triangle Center of Excellence in Regulatory Science and Innovation
Univ of North Carolina Chapel Hill
FY2025$525,000U01FD007857 - Research Triangle Center of Excellence in Regulatory Science and Innovation
Univ of North Carolina Chapel Hill
FY2024$2,033,969U01FD007857 - Research Triangle Center of Excellence in Regulatory Science and Innovation
Univ of North Carolina Chapel Hill
FY2024$949,206U01FD007857
Congress activity
Updated 27 Aug 2026
6 congress contributions (2018–2020) across ADA per OpenAlex. The most recent:
- 1144-P: Patient Phenotypes and SGLT2 Inhibition in Type 2 Diabetes Mellitus: Insights from the EMPA-REG OUTCOME Trial
ADA Scientific Sessions
ADA2020Co-authorPoster - 958-P: Once-Weekly Exenatide Effects on EGFR Slope and UACR as a Function of Baseline UACR: An EXSCEL Trial Post Hoc Analysis
ADA Scientific Sessions
ADA2020Co-authorPoster - 6-LB: Effect of Open-Label SGLT2 Inhibitor Treatment When Combined with Exenatide on Cardiovascular and Renal Outcomes in EXSCEL
ADA Scientific Sessions
ADA2019Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Implementation of a Digital Patient Activation Tool to Engage Patients With Heart Failure in Intensification of Guideline-Directed Medical Therapies.
Computers, informatics, nursing
Article2026 - In-Hospital or Out-of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE-HF Trial.
Journal of the American Heart Association
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03
- 05Palliative Care in Heart Failure601 citations2017
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/robert-mentz-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/rob-mentz-54318087
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Robert-Mentz-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Spotify
open.spotify.com/episode/2gumC2zJ0ZDYB2z7L2KgGW
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →open.spotify.com ↗ - Spotify
drjourneytobetter.com/2084093/episodes/15988739-dr-robert-mentz-leading-with-inclusivity-and-innovation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →drjourneytobetter.com ↗ - X / Twitter
x.com/dukehrtfailure
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
- Board Certified
American Board of Internal Medicine - Cardiovascular Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗ - Board Certified
American Board of Internal Medicine - Advanced Heart Failure and Transplant Cardiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
Editorial & leadership roles
journal and society appointments- Co-Editor-in-Chief
Journal of Cardiac Failure (official journal of the Heart Failure Society of America and Japanese Heart Failure Society); sole Editor-in-Chief 2020-2024, Co-Editor-in-Chief since Sept 1
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗ - Chief
Heart Failure Section, Duke University Division of Cardiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.duke.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scholars.duke.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.duke.edu ↗
- Co-PI
FDA Research Triangle Center of Excellence in Regulatory Science and Innovation (CERSI)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scholars.duke.edu ↗
Media & interviews
press, podcasts and appearances- CardioNerds: A Cardiology Podcast - Episode 388
'Ironing out the Data: Iron Deficiency in Heart Failure with Dr. Robert Mentz'
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardionerds.com ↗ - CardioNerds Podcast - Episode 36
'Diuretics, ARNi, SGLT2/GLP1 therapies and iron for HFpEF with Dr. Robert Mentz'
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →backtracks.fm ↗ - Parallax Podcast (Radcliffe Cardiology)
HFSA Edition: 'Diversity, Equity, Inclusion & Belonging with Robert Mentz & Anuradha Lala'
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radcliffecardiology.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
William Kraus, MD
Duke University School of Medicine
Angeles Secord, MD
Duke University School of Medicine
Virginia Kraus, MD, PhD
Duke University School of Medicine
Neal Ready, MD
Duke University School of Medicine